Efficacy of Nitazoxanide against Cryptosporidium parvum in Cell Culture and in Animal Models

Nitazoxanide (NTZ), a drug currently being tested in human clinical trials for efficacy against chronic cryptosporidiosis, was assessed in cell culture and in two animal models. The inhibitory activity of NTZ was compared with that of paromomycin (PRM), a drug that is partially effective against Cry...

Descripción completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Autores principales:	Theodos, Cynthia M., Griffiths, Jeffrey K., D’Onfro, Jennifer, Fairfield, Alexandra, Tzipori, Saul
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	American Society for Microbiology (ASM) 1998
Materias:	Experimental Therapeutics
Acceso en línea:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105716/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9687390/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.8.1959
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!